Literature DB >> 17827947

Small intestinal bacterial overgrowth: diagnosis and treatment.

Antonio Gasbarrini1, Ernesto Cristiano Lauritano, Maurizio Gabrielli, Emidio Scarpellini, Andrea Lupascu, Veronica Ojetti, Giovanni Gasbarrini.   

Abstract

Small intestinal bacterial overgrowth (SIBO) is a clinical condition characterized by a malabsorption syndrome due to an increase in microorganisms within the small intestine. The main mechanisms restricting bacterial colonization in the upper gut are the gastric acid barrier, mucosal and systemic immunity and intestinal clearance. When these mechanisms fail, bacterial overgrowth develops. Diarrhea, steatorrhea, chronic abdominal pain, bloating and flatulence are common symptoms and are similar to those observed in irritable bowel syndrome. Breath tests (glucose and/or lactulose breath tests) have been proposed as a sensitive and simple tool for the diagnosis of bacterial overgrowth, being non-invasive and inexpensive compared to the gold standard represented by the culture of intestinal aspirates. Antibiotic therapy is the cornerstone of SIBO treatment. Current SIBO treatment is based on empirical courses of broad-spectrum antibiotics since few controlled studies concerning the choice and duration of antibiotic therapy are available at present. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827947     DOI: 10.1159/000103892

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  53 in total

1.  Small intestinal bacterial overgrowth among patients with celiac disease unresponsive to a gluten free diet.

Authors:  Mohammad-Ayman A Safi; Asif A Jiman-Fatani; Omar I Saadah
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

2.  Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

3.  Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease.

Authors:  Xiao-Lu Niu; Li Liu; Zhi-Xiu Song; Qing Li; Zhi-Hua Wang; Jian-Long Zhang; He-Hua Li
Journal:  J Neural Transm (Vienna)       Date:  2016-09-02       Impact factor: 3.575

Review 4.  Radiation enteritis.

Authors:  Ali H Harb; Carla Abou Fadel; Ala I Sharara
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 5.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

6.  Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease.

Authors:  Matthew S Chang; Maria T Minaya; Jianfeng Cheng; Bradley A Connor; Suzanne K Lewis; Peter H R Green
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

7.  Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome.

Authors:  Suma Magge; Anthony Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-11

Review 8.  Ileostomy diarrhea: Pathophysiology and management.

Authors:  Kyle M Rowe; Lawrence R Schiller
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

Review 9.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

Review 10.  Update on chronic diarrhea: a run-through for the clinician.

Authors:  Davinder K Sandhu; Christina Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.